{"id":19885,"date":"2020-06-15T11:41:03","date_gmt":"2020-06-15T09:41:03","guid":{"rendered":"https:\/\/www.satt.fr\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/"},"modified":"2020-06-15T11:41:03","modified_gmt":"2020-06-15T09:41:03","slug":"xav-19-xenothera-lance-ses-essais-cliniques-en-juillet","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/","title":{"rendered":"Xav-19, Xenothera lance ses essais cliniques en juillet"},"content":{"rendered":"<p>La start-up nantaise, Xenothera a d\u00e9velopp\u00e9 Xav-19, un traitement contre le covid-19. Elle lance ses essais cliniques sur quelques dizaines de patients au CHU de Nantes d\u00e9but juillet.\u00a0<\/p>\n<p><a href=\"https:\/\/www.ouest-valorisation.fr\/fr\/portfolio\/technologies-xav-19-traitement-contre-le-covid-19\/\">En savoir plus<\/a><\/p>\n<p><strong>\u00c0 propos de Xenothera<\/strong><\/p>\n<p>Suite au programme de maturation financ\u00e9 par Ouest Valorisation, la soci\u00e9t\u00e9 XENOTHERA, cr\u00e9\u00e9e en 2014, a acquis une licence d\u2019exploitation, conc\u00e9d\u00e9e par la SATT pour le compte de l\u2019Universit\u00e9 de Nantes, du CHU de Nantes et de l\u2019Inserm.<\/p>\n<p>La biotech nantaise d\u00e9veloppe des anticorps polyclonaux \u00ab humanis\u00e9s \u00bb. Sa plateforme technologique est b\u00e2tie sur une double expertise de g\u00e9n\u00e9tique animale et de ma\u00eetrise de l\u2019immunologie. L\u2019entreprise a un portefeuille complet de produits, dont le premier, le LIS1, un immunosuppresseur dans la transplantation, est en clinique depuis 2019. XENOTHERA s\u2019inscrit dans l\u2019environnement scientifique, m\u00e9dical et acad\u00e9mique nantais et est soutenu par Atlanpole, p\u00f4le de comp\u00e9titivit\u00e9 de la r\u00e9gion Pays de la Loire. Depuis sa cr\u00e9ation, l\u2019entreprise a lev\u00e9 6 millions d\u2019euros et a re\u00e7u le soutien de la BPI.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up nantaise, Xenothera a d\u00e9velopp\u00e9 Xav-19, un traitement contre le covid-19. Elle lance ses essais cliniques sur quelques dizaines de patients au CHU de Nantes d\u00e9but juillet.\u00a0 En savoir plus \u00c0 propos de Xenothera Suite au programme de maturation financ\u00e9 par Ouest Valorisation, la soci\u00e9t\u00e9 XENOTHERA, cr\u00e9\u00e9e en 2014, a acquis une licence d\u2019exploitation, [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":19881,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-19885","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xav-19, Xenothera lance ses essais cliniques en juillet - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Guedon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\"},\"author\":{\"name\":\"Anne Guedon\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"headline\":\"Xav-19, Xenothera lance ses essais cliniques en juillet\",\"datePublished\":\"2020-06-15T09:41:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\"},\"wordCount\":193,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\",\"url\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\",\"name\":\"Xav-19, Xenothera lance ses essais cliniques en juillet - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png\",\"datePublished\":\"2020-06-15T09:41:03+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png\",\"width\":1268,\"height\":708},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xav-19, Xenothera lance ses essais cliniques en juillet\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\",\"name\":\"Anne Guedon\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/anne\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xav-19, Xenothera lance ses essais cliniques en juillet - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/","twitter_misc":{"Written by":"Anne Guedon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/"},"author":{"name":"Anne Guedon","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"headline":"Xav-19, Xenothera lance ses essais cliniques en juillet","datePublished":"2020-06-15T09:41:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/"},"wordCount":193,"image":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/","url":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/","name":"Xav-19, Xenothera lance ses essais cliniques en juillet - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png","datePublished":"2020-06-15T09:41:03+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/XAv.png","width":1268,"height":708},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/xav-19-xenothera-lance-ses-essais-cliniques-en-juillet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Xav-19, Xenothera lance ses essais cliniques en juillet"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e","name":"Anne Guedon","url":"https:\/\/www.satt.fr\/en\/author\/anne\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/19885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=19885"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/19885\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/19881"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=19885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=19885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=19885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}